In this case, the use of PRAME as an immunohistochemical marker could be a valuable diagnostic aid; indeed, PRAME, which is expressed in melanoma but not in most sarcomas, could be an important discriminatory tool, improving the diagnostic accuracy of AAM [40,41,42,43,44]. The gene discussed is PRAME; the disease is melanoma.